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proliferation, and fusion. PLs have a glycerophosphate 
backbone structure, and the polar head group is linked to 
the sn-3 position and the acyl chains are linked to the sn-1/
sn-2 positions. Saturated or mono-unsaturated fatty acids, 
such as palmitic acid (16:0), stearic acid (18:0), and oleic acid 
(18:1), are mainly located in the sn-1 position. On the other 
hand, PUFAs, such as linoleic acid (18:2), arachidonic 
acid (AA; 20:4), EPA (20:5), and DHA (22:6), are mainly 
located in the sn-2 position. Thus, oxidized PUFAs that are 
generated by oxygenases and/or by reactive oxygen spe-
cies are usually located in the sn-2 position of PLs. Some of 
those oxidized PLs (OxPLs) are biologically active and are 
thought to be associated with pathogenesis of various dis-
eases, such as arteriosclerosis, diabetes, and cancer (1–4). 
However, the biosynthesis and metabolism of each OxPL 
molecular species has not been well-characterized.
HPLC-UV and/or the analysis of thiobarbituric acid-
reactive substances have conventionally been applied to 
monitor OxPL levels (5, 6). However, those methods are 
not designed to determine differences in the molecular 
species of OxPLs. LC-MS/MS analysis with multiple reaction 
monitoring (MRM) mode has recently been used to ana-
lyze PLs and OxPLs because this method can determine 
acyl chain composition by monitoring a particular pair of 
precursor and fragment ions corresponding to the acyl 
chains at a specified retention time (7–13). Recently, 
O’Donnell and colleagues developed an excellent global 
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lipidomic workflow that can monitor low abundant and un-
known molecular species, including OxPLs (14, 15). In this 
procedure, untargeted lipidomics was first performed by 
high-resolution MS, and all detected ions were putatively 
identified using an online database based on m/z values 
without fragmentation. Then, the structural identification 
of selected ions was performed based on MS/MS spectra 
and MRM mode was applied for validation. They showed 
the presence of more than 100 molecular species of OxPLs 
by applying this procedure to the activated human plate-
lets. However, the structure of oxidized fatty acyl chains in 
many molecular species of the OxPLs were not determined 
because of the low abundance of OxPLs generated by hu-
man platelets, and the diagnostic fragments of oxidized 
fatty acyl chains were hardly acquired. In this study, we first 
aimed to develop a precise MS/MS spectra library for OxPLs 
using a series of biogenic materials. Untargeted lipidomics 
was applied to collect MS/MS spectra for biogenic OxPLs 
prepared by the addition of oxidized fatty acids to HEK293 
cells, where they were incorporated into cellular PLs. This 
procedure made it easier to identify the precise OxPL struc-
tures based on MS/MS spectra, because oxidized fatty acid 
was selectively incorporated into cellular PLs that produce 
selective OxPL molecular species. By using these MS/MS 
spectra for biogenic OxPLs, we successfully optimized MRM 
conditions and developed a broad-targeted lipidomics sys-
tem to monitor about 400 molecular species of OxPLs si-
multaneously. This system will be useful to determine the 
physiological relevance of OxPLs in health and diseases.
MATERIALS AND METHODS
Materials
PLs, 1-stearoyl-2-arachidonoyl-3-PLs [phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), phos-
phatidylserine (PS), and phosphatidylglycerol (PG)], 1-heptadec-
anoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-PLs [PC, PE, PI, PS, and 
PG], 1-stearoyl-2-linoleoyl-sn-glycero-3-PC, and 1-stearoyl-2-doco-
sahexaenoyl-sn-glycero-3-PE were obtained from Avanti Polar Lipids 
(Alabaster, AL). Oxidized fatty acids, HETE, hydroxyeicosapen-
taenoic acid (HEPE), hydroxydocosahexaenoic acid (HDoHE), 
HODE, epoxyeicosatrienoic acid (EET), epoxyeicosatetraenoic 
acid (EpETE), and epoxydocosapentaenoic acid (EpDPE), were 
obtained from Cayman Chemical (Ann Arbor, MI). Soybean 
15-lipoxygenase (LOX) (type I-B), sodium borohydride, acetic 
acid, deoxycholate, and all solvents of LC-MS grade were obtained 
from Sigma-Aldrich (St. Louis, MO).
Preparation of biogenic OxPLs
HEK293 cells were cultured in DMEM supplemented with 10% 
FCS (Gibco, Carlsbad, CA) and 100 U/ml penicillin (Gibco), 100 
g/ml streptomycin (Gibco), and 2 mM L-glutamine (Gibco) in 
a 37°C incubator with 5% CO2 in air. For preparation of OxPLs, 
HEK293 cells (1.0 × 106 cells) were plated on a 6 cm dish and in-
cubated with 10 M of oxidized fatty acids for 1 h. Cells were 
harvested in ice-cold methanol and were extracted by solid-phase 
extraction using a monospin C18 column (GL Sciences, Tokyo, 
Japan). Briefly, the samples were applied to a monospin C18 col-
umn preconditioned with 300 l methanol and 300 l water and 
then washed with 300 l water and 300 l hexane followed by the 
elution with 250 l isopropanol. The phosphorus content of the 
extracted lipids was quantified by the method of Bartlett (16); the 
extracted lipids were reconstituted to 1 mM phosphorus with 
chloroform:methanol (1:2) and then stored at 80°C until use.
Measurement of OxPL levels in primary mouse peritoneal 
macrophages
Male C57BL/6J mice (11 weeks) were obtained from CLEA 
Japan, Inc. (Tokyo, Japan). The 12/15-LOX knockout mice on a 
C57BL/6 background were from the Jackson Laboratory (Bar 
Harbor, ME). Peritoneal cells were obtained by lavage and macro-
phages were isolated by adherence to plastic culture plates in 
RPMI1640 medium supplemented with 10% FCS for 2 h at 37°C. 
Adherent cells were harvested and lipids were extracted by solid-
phase extraction, as described above. As internal standards, PC 
(17:0/14:1), PE (17:0/14:1), PI (17:0/14:1), PS (17:0/14:1), 
and PG (17:0/14:1) were added at a final concentration of 
100 nM each. The extracted lipids were reconstituted in 40 l of 
chloroform:methanol (1:2) and were stored at 80°C until use. 
All experiments were approved by the RIKEN Yokohama Campus 
Animal Use Committee and performed in accordance with the 
committee’s guidelines.
Untargeted lipidomics
Untargeted lipidomics was performed using an ACQUITY 
UPLC system (Waters, Milford, MA) coupled with a quadrupole/
TOF MS (TripleTOF 5600+ and TripleTOF 6600; Sciex, Framing-
ham, MA). LC separation was performed using a reverse-phase 
column [ACQUITY UPLC BEH peptide C18 (50 × 1.7 mm inner 
diameter, 2.1 m particle size; Waters)] with a gradient elution of 
mobile phase A [methanol/acetonitrile/water (1:1:3, v/v/v) con-
taining 5 mM ammonium acetate (Wako Chemicals, Osaka, 
Japan) and 10 nM EDTA (Dojindo, Kumamoto, Japan)] and mo-
bile phase B (100% isopropanol containing 5 mM ammonium 
acetate and 10 nM EDTA); the composition was produced by 
mixing those solvents. The LC gradient consisted of a holding 
solvent (A/B:100/0) for 1 min, then linearly converting to solvent 
(A/B:60/40) for 4 min, linearly converting to solvent (A/B:36/64) 
for 2.5 min, and holding for 4.5 min, then linearly converting to 
solvent (A/B:17.5/82.5) for 0.5 min, linearly converting to sol-
vent (A/B:5/95) for 1 min followed by returning to solvent 
(A/B:100/0) and holding for 5 min for re-equilibration. The in-
jection volume was 2 l, the flow rate was 0.300 ml/min, and col-
umn temperature was 45°C. Information-dependent acquisition 
(IDA) mode was applied to confirm each of the biogenic OxPL 
structures. The source conditions were as follows: temperature, 
300°C; curtain gas, 25 psi; ion source gas 1 and 2 at 80 and 40 psi; 
and ion spray voltage floating at 5.5 kV. The acquisition con-
ditions were as follows: the accumulation time for full scan was 
100 ms for scanning a mass range from m/z 75 to m/z 1,250. The 
accumulation time for each IDA experiment was 50 ms, and col-
lision energies (CEs) were set to 3560 eV with a CE spread of 15 
eV in high-resolution mode. IDA criteria were as follows: 10 most 
intense ions with an intensity threshold above 100 cps, isotope ex-
clusion was set to 1.5 Dam, and an exclusion time of 10 s was set.
Broad-targeted analysis
Broad-targeted analysis was performed using an ACQUITY UPLC 
system coupled with a triple quadrupole (tripleQ) MS (QTRAP 
6500; Sciex). LC separation was performed using a reverse-phase 
column [ACQUITY UPLC HSS T3 (50 × 2.1 mm inner diameter, 
1.8 m particle size; Waters)] with a gradient elution of mobile 
phase A [methanol/acetonitrile/water (1:1:3, v/v/v) containing 
50 mM ammonium acetate and 10 nM EDTA] and mobile phase 
B (100% isopropanol containing 50 mM ammonium acetate and 
10 nM EDTA); the composition was produced by mixing those 
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for 1 min, then linearly converting to solvent (A/B:50/50) for 
4 min, linearly converting to solvent (A/B:36/64) for 7 min, then 
linearly converting to solvent (A/B:5/95) for 1 min and holding 
for 1 min followed by returning to solvent (A/B:100/0) and 
holding for 5 min for re-equilibration. The injection volume was 
3.5 l, the flow rate was 0.350 ml/min, and column temperature 
was 50°C. MRM mode was applied to detection of OxPLs in bio-
logical samples. Selected MRM transitions and CEs are described 
in Table 1 and supplemental Table S1. For quantification, OxPL 
standard solutions corresponding to 10, 20, 50, 100, 200, and 
500 nM were prepared to acquire calibration curves for concen-
tration and efficiency of ionization. One microliter of those solu-
tions was injected and measured as described above. Calibration 
curves were obtained from the concentrations and the area of in-
tensity of each OxPL.
Preparation of purified OxPL standards by soybean 15-LOX
OxPL standards were generated in accordance with a previ-
ous method (10). Briefly, PC (18:0/20:4), PE (18:0/20:4), PI 
(18:0/20:4), PS (18:0/20:4), and PG (18:0/20:4) were incubated 
with soybean 15-LOX in 0.2 M borate buffer (pH 9.0) and 10 mM 
deoxycholate at room temperature. The oxidation reaction was 
monitored by its absorbance at 234 nm and was terminated at 
30 min. Hydroperoxide intermediates were reduced with excess 
sodium borohydride and incubations were extracted by using a 
monospin C18 column as described above. To separate and iso-
late conversion products, reverse-phase HPLC was carried out by 
using a Waters XBridge C18 column (100 × 4.6 mm inner diame-
ter, 5 m particle size; Waters) with mobile phase A [methanol/
water (1:1) containing 0.01% acetic acid] and mobile phase B 
(100% methanol) at 0.7 ml/min of flow rate for PC and PE, and 
an ACQUITY UPLC HSS T3 (75 × 3.5 mm inner diameter, 1.8 m 
particle size; Waters) with mobile phase A [methanol/acetoni-
trile/water (1:1:3, v/v/v) containing 50 mM ammonium acetate 
and 10 nM EDTA] and mobile phase B (100% isopropanol con-
taining 50 mM ammonium acetate and 10 nM EDTA) at 0.6 ml/
min for PI, PG, and PS. The concentration of purified standards 
was assessed by LC-MS/MS after saponification with 0.2 M NaOH 
at 60°C for 30 min in 50% isopropanol.
Preparation of positional isomer mixtures of OxPL 
standards by air oxidation
Positional isomer mixtures of OxPL standards were generated by 
air oxidation in accordance with a previous method (10). Briefly, 
10 mM 2,2,5,7,8-pentamethyl-6-chromanol (Sigma-Aldrich) were 
added to PC (18:0/20:4), PE (18:0/20:4), PE (18:0/22:6), and PC 
(18:0/18:2), and they were dried up under nitrogen gas. Then, 
the samples were incubated at 37°C for 24 h followed by resuspen-
sion in methanol containing 20 mg/ml butylated hydroxytoluene 
(Sigma-Aldrich). Lipids were extracted by using a monospin C18 
column, as described above. To purify conversion products, re-
verse-phase HPLC was carried out by using a Waters XBridge C18 
column (100 × 4.6 mm inner diameter, 5 m particle size; Waters) 
with mobile phase A [methanol/acetonitrile/water (1:1:3, v/v/v) 
containing 0.1% acetate and 10 nM EDTA] and mobile phase B 
(100% isopropanol containing 0.1% acetate and 10 nM EDTA) at 
1.0 ml/min. The concentration of purified standards was assessed 
by LC-MS/MS after saponification with 0.2 M NaOH at 60°C for 
30 min in 50% isopropanol.
Statistical analysis
Results are expressed as mean ± SE. Differences between two 
groups were tested by the Student’s t-test. A significance level of 
P < 0.05 was used.
RESULTS
Construction of a measured MS/MS spectra library for 
OxPLs
To acquire MS/MS spectra for OxPLs, we devised a 
method to prepare various types of OxPLs by use of bio-
genic conversion from oxidized fatty acids incorporated 
into cellular PLs. Oxidized fatty acids, such as hydroxyl and 
epoxy-containing fatty acids, were added to HEK293 cells 
for 1 h, cells were harvested, and lipids were extracted. 
Lipid fractions were analyzed by LC-quadrupole/TOF 
(QTOF)-MS-based untargeted lipidomics to collect MS/
MS spectra for each of the biogenic OxPLs. This method 
provides automatic MS to MS/MS switching by setting the 
MS/MS trigger at a low threshold level of intensity and 
then information-rich MS/MS spectra with high resolution 
could be acquired in a nonbiased fashion (17–19). For ex-
ample, many types of lipids, such as lyso-PLs, PLs, and sphin-
golipids, were readily detected in lipid extracts of HEK293 
TABLE 1. Representative optimized MRM transitions for OxPLs detected by untargeted lipidomics
Head Adduct Ion sn-1 sn-2 Q1 (m/z) Q3 (m/z) CE (eV) Retention Time (min)
PC [M+CH3COO]
 16:0 5-HETE 856.6 115.0 47 9.2
8-HETE 856.6 155.1 47 8.7
12-HETE 856.6 179.1 50 8.5
15-HETE 856.6 219.1 50 8.2
18-HETE 856.6 261.2 56 7.8
20-HETE 856.6 289.2 56 7.7
5-HEPE 854.6 115.0 46 8.6
8-HEPE 854.6 155.1 52 8.1
15-HEPE 854.6 219.1 49 7.5
7-HDoHE 880.6 141.1 47 8.8
10-HDoHE 880.6 153.1 53 8.4
17-HDoHE 880.6 245.2 47 8.2
20-HDoHE 880.6 285.2 44 8.0
14,15-EET 856.6 219.1 47 8.8
8,9-EpETE 854.6 155.1 41 8.6
11,12-EpETE 854.6 179.1 47 8.4
14,15-EpETE 854.6 219.1 47 8.3
17,18-EpETE 854.6 259.2 44 8.1
19,20-EpDPE 880.6 285.2 44 8.6
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cells and the candidate signals for PLs containing 12-HETE 
were obtained in 12-HETE-treated cells, as determined by 
the presence of a fragment ion (m/z 319.2) corresponding to 
mono-oxidized AA (abbreviated as AA+O) (Fig. 1). MS/MS 
data of those candidate signals were further carefully inves-
tigated and diagnostic fragment ions for accurate identifi-
cation were determined. For example, PC (16:0/12-HETE) 
was identified by the precursor ion (m/z 856.5) and fragment 
ions of acyl chains (m/z 255.2→16:0, m/z 319.2→AA+O), 
neutral loss ion of the choline part ([M+CH3COO-74]
), 
and 12-HETE-specific fragment ion (m/z 179.1), which 
could distinguish it from other HETEs (Fig. 2). In total, 12 
types of OxPC, 8 types of OxPE, 3 types of OxPI, and 2 types 
of OxPS were identified in extracts from 12-HETE-treated 
cells (Table 1). This procedure was also applied to other 
oxidized fatty acids, i.e., HETEs, HEPEs, HDoHEs, HODEs, 
EETs, EpETEs, and EpDPEs, in order to expand the MS/MS 
spectra library. Characteristic fragment ions for identification 
of those OxPLs were individually optimized and MS/MS 
data of 386 total molecular species were successfully ac-
quired (Fig. 2, Table 1, supplemental Table S1). Full MS/MS 
spectra data are deposited in the “Computational MS-based 
metabolomics” section of the RIKEN PRIMe website (http://
prime.psc.riken.jp/Metabolomics_Software/MS-DIAL/ 
index.html).
Development of a specific and highly sensitive analytical 
system for OxPLs
The abundance of OxPLs in biological samples is normally 
low and many of them are short-lived and structurally simi-
lar (9–15). Therefore, the development of a highly specific 
and sensitive method to monitor OxPL molecular species 
in vivo is important to understand their physiological and/or 
pathophysiological roles. MRM analysis with a particular 
pair of precursor and fragment ions at a specified retention 
time using LC tripleQ MS was applied to demonstrate 
Fig. 1. 2D map of mass versus LC retention time of lipids isolated from control and 12-HETE-treated cells. 
The 2D map has the m/z values of precursor ions along the vertical axis and the retention times (RT) along 
the horizontal axis. A: Plots of precursor ions identified as lyso-PLs, PLs, and sphingolipids. B: Plots of candi-
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Fig. 2. Structural identification of OxPLs by MS/MS fragmentation patterns. Structural analysis of candidate signals obtained from a series 
of biogenic OxPLs. Based on the MS/MS spectra, the OxPL structures were assigned to the corresponding fragments of the acyl chains, the 
diagnostic ions of molecular species of oxidized fatty acids, and the head groups or neutral loss ions of the head groups. GPhE, phosphoglyc-
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broad-targeted analysis of OxPLs. Based on the frag-
mentation patterns of MS/MS spectra library, MRM transi-
tions from a targeted precursor ion to its specific fragment 
ion were carefully selected to avoid peak overlapping for 
individual OxPL molecular species. For example, struc-
tural differences of OxPLs, such as PC (16:0/5-HETE), PC 
(16:0/8-HETE), PC (16:0/12-HETE), and PC (16:0/ 
15-HETE), were distinguished by the optimized MRM 
transitions, as depicted in Fig. 3A. In the case of OxPLs 
whose MS/MS spectra could not be acquired by untargeted 
lipidomics, we predicted fragmentation patterns for them 
to expand the measurement range as predictive MRM. LC 
gradient conditions were also optimized to separate similar 
OxPL structural isomers (Fig. 3B). The CE was optimized 
by determining the most sensitive value for each biogenic 
OxPL individually. The optimized MRM conditions for 
Fig. 3. OxPL detection by LC tripleQ MS with optimized MRM transitions and LC gradient conditions. A: 
A series of biogenic OxPCs containing HETEs were selectively detected by optimized MRM transitions. B: 
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each OxPL molecular species are summarized in Table 1 
and supplemental Table S1.
Preparation of purified OxPL standards for determination 
of the linear ranges and the lower limits of detection
To determine the linear ranges and the lower limits of 
detection in our analytical system, purified standard com-
pounds were prepared using an in vitro LOX reaction. 
OxPLs containing 15-HETE as representative OxPL stan-
dards were prepared by in vitro oxidation of PC (18:0/20:4), 
PE (18:0/20:4), PI (18:0/20:4), PS (18:0/20:4), and PG 
(18:0/20:4) using soybean 15-LOX. The concentrations of 
the OxPL standards were assessed by measuring the amount 
of oxidized fatty acids after saponification (20, 21). The 
peak areas were acquired by OxPC, OxPE, OxPI, OxPS, 
and OxPG standard solutions corresponding to 10, 20, 50, 
100, 200, and 500 nM (Fig. 4). The linear ranges were be-
tween 10 and 500 fmol for OxPC, OxPE, OxPI, and OxPG 
and between 50 and 500 fmol for OxPS. These results sug-
gested that the lower limits of detection in our OxPL lipi-
domics system were 10 fmol for OxPC, OxPE, OxPI, and 
OxPG and 50 fmol for OxPS on column (19–21).
Fig. 4. Calibration curves for quantification of OxPLs. OxPL standard solutions corresponding to 10, 20, 50, 100, 200, and 500 fmol were 
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Application of the OxPL lipidomics system to a biological 
sample
To determine whether this OxPL lipidomics system was 
applicable to biological samples, we applied it to mouse 
peritoneal macrophages. Previously, it was reported that 
mouse peritoneal macrophages express a cytosolic LOX, 
12/15-LOX, and contain a series of OxPLs endogenously 
produced by the 12/15-LOX activity (11). Lipids were ex-
tracted from mouse peritoneal macrophages and the lipid 
fractions were applied to LC-MS/MS-based OxPL lipidomics 
with optimized MRM conditions. The extraction efficiency 
was normalized using PC (17:0/14:1), PE (17:0/14:1), and 
PI (17:0/14:1) as internal standards. Using this approach, 
20 molecular species of OxPLs containing 12-HETE, 15-
HETE, 14-HDoHE, 9-HODE, and 13-HODE were success-
fully detected (Fig. 5). To quantify the amount of those 
OxPLs, we prepared positional isomer mixtures of OxPL 
standards by air oxidation of PC (18:0/20:4), PE (18:0/20:4), 
PE (18:0/22:6), and PC (18:0/18:2), and constructed cali-
bration curves (supplemental Fig. S1). As a result of quan-
tification using these calibration curves, the total amounts 
of OxPC, OxPE, and OxPI were estimated to be 1180.3, 
936.5, and 80.7 fmol per 1.0 × 106 macrophages, respectively. 
These results were consistent with the previous report (11). 
Also, a series of OxPLs containing 12/15-LOX products, 
such as 12-HETE and 14-HDoHE, were clearly detected 
in WT macrophages, but were much less abundant in 
12/15-LOX-deficient macrophages (Fig. 5). These results 
suggest that our LC-MS/MS-based lipidomics system is sen-
sitive enough to monitor individual OxPL molecular spe-
cies present in biological samples.
DISCUSSION
In this study, we first constructed a measured MS/MS 
spectra library by applying untargeted lipidomics to biogenic 
OxPLs prepared by the addition of oxidized fatty acids to 
cultured cells. Based on the MS/MS spectra for each OxPL 
molecular species, we developed a broad-targeted lipido-
mics system by MRM mode. We applied this system to 
mouse peritoneal macrophages and quantified a series of 
OxPLs endogenously produced in a 12/15-LOX-dependent 
manner. These results indicate that our lipidomics system 
will be applicable to the comprehensive analysis of OxPLs 
present in biological samples.
The previous analytical limitations were due to the lack 
of various types of OxPL standards. To solve this problem, 
we conceived the idea to prepare various types of OxPLs 
by adding different types of oxidized fatty acids to HEK293 
cells, because these exogenous oxidized fatty acids would 
be incorporated into the cellular PLs by lyso-PL acyltrans-
ferase (22, 23). In this study, a total of 29 types of oxidized 
fatty acids were added to HEK293 cells and about 400 mo-
lecular species of OxPLs were identified by untargeted 
lipidomics. Interestingly, some of these OxPLs had unique 
incorporation patterns for PLs. For example, 15-HETE and 
18-HEPE were effectively incorporated into PI; whereas, 
12-HETE was preferentially incorporated into PC. Those 
preferences for oxidized fatty acids may depend on the sub-
strate specificities of the lyso-PL acyltransferases. Therefore, 
it might be possible to expand the biogenic MS/MS spectra 
library by manipulating these enzyme activities.
We also found that the LC retention time for OxPLs 
appeared to be affected by the hydroxyl and epoxy group 
position in the oxidized fatty acyl chains. For example, ep-
oxy-containing OxPLs eluted later than hydroxyl-contain-
ing OxPLs, and OxPLs whose hydroxyl or epoxy group was 
located closer to the end of acyl chain eluted earlier than 
other OxPLs. Also, the optimal CE condition appeared to 
be dependent on the PL head group rather than on the 
molecular species of oxidized fatty acyl chains (Table 1, 
supplemental Table S1).
Fig. 5. Quantification of OxPLs in mouse peritoneal macrophages. Peritoneal macrophages isolated from 
WT and 12/15-LOX KO mice were analyzed. Levels of OxPLs were expressed as concentration per 1.0 × 106 
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A previous study reported that 12/15-LOX-dependent 
OxPL production by mouse peritoneal macrophages 
maintains immunogenic tolerance by interfering with 
MFG-E8-mediated uptake of apoptotic cells into inflam-
matory monocytes (24). A series of OxPLs containing 12-
HETE, 15-HETE, and 14-HDoHE were identified in those 
macrophages. OxPLs are also formed in other cell types, 
such as neutrophils, platelets, and dendritic cells (DCs) 
(25–28). These OxPLs are thought to have various phys-
iological functions, such as production of neutrophil ex-
tracellular traps, thrombin generation of platelets, and 
regulation of DC maturation and function (25, 26, 28). Ap-
plication of the present method to those biological samples 
would enable us to monitor the structure-specific behavior 
of OxPLs that could lead to the elucidation of their physi-
ological relevance.
In summation, we constructed a broad-targeted lipido-
mics system for OxPLs based on the fragmentation pat-
terns of a measured MS/MS spectra library. This lipidomics 
system will enable us to monitor OxPLs comprehensively 
and will help us to understand their physiological signifi-
cance in a quantitative and qualitative manner.
The authors thank Y. Senoo for technical assistance.
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